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INTRODUCTION 
 
Globally, more than half of the diabetic subjects die from coronary artery disease  
(CAD) (1). Another large portion of the patients suffer from cerebral infarction 
and peripheral vascular disease, mainly due to markedly advanced atherosclerosis.  
         The U.K. Prospective Diabetes Study (2) and Finnish studies (3) have shown an  
association of the HbA1c level and the risk for CAD in type 2 diabetic patients.  
          Intima-media thickness (IMT) of the carotid artery has been used as a subclinical index      
 of atherosclerosis (4–14). Several studies have shown an association between increased  
carotid IMT and new myocardial infarction  in elderly and middleaged subjects (13–14).  
        Study of carotid IMT in type 2 diabetic Asian subjects is of particular  
interest, because the prevalence and incidence of atherosclerotic vascular disease  
in the Asian general population is much higher than that in Western populations(15-16).  
          Cardiovascular  events have been used as reliable end points for atherosclerosis 
intervention trials and epidemiological cohort studies. Ultrasonographic 
measurement of carotid artery intima-media thickness (IMT) allows the  
noninvasive and early detection of atherosclerotic changes and is used as a  
noninvasive end point for assessing the progression and regression of  
atherosclerosis in clinical trials (1-14,17). It was previously reported that IMT was 
closely associated with not only the incidence of cerebrovascular disease, but also  
with that of coronary artery disease (CAD) in elderly and middle-aged subjects(13-14,18-20).  
 
              However, it has not been fully confirmed that IMT can be used as a  
predictor of CAD in diabetic patients. A few previous studies have evaluated the 
association between carotid IMT and CAD in patients with type 2  
diabetes (8,20-21). In these studies, CAD was diagnosed from symptoms and  
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clinical records rather than by objective testing for evidence of CAD. It has been  
reported that diabetic patients often have diffuse and multiple cardiovascular  
stenoses, despite having less symptoms than nondiabetic subjects. In fact, the  
onset of CAD may be a severe or fatal event in diabetic patients. The prognosis of 
cardiovascular events in diabetic patients tends to be worse than that in  
nondiabetic subjects. However, there is no general agreement regarding  
the best way to screen asymptomatic diabetic patients for significant CAD (20).  
        It is important to develop a simple method of detecting coronary artery disease at 
an early stage in diabetic patients. In the present study, we investigated the 
association between carotid atherosclerosis (measured from IMT) and CAD 
confirmed by Treadmill Testing and Echocardiography in  patients with type 2 
diabetes. 
              Various studies have shown that IMT increases mm/year in known cases of  
 
Cardiovascular disease (CVD)  (22). Hence IMT increase can be regarded as a marker  
 
of generalized atherosclerosis and atherosclerosis of coronary arteries (23,24). On the  
 
other hand, IMT is related to coronary risk factors such as age, smoking,  
 
hypertension, and LDL-C (25). In a number of  recent studies, cholesterol  
 
lowering medications led to decrease in IMT (26-29). These studies suggest that  
 
IMT is of high value as a marker of atherosclerosis. There have also been studies  
 
on the relationship between CAD and ultrasonographic variables with mixed  
 
results on how carotid IMT relates to CAD (30-33). Individuals with atherosclerotic coronary  
 
arteries remain symptom-free for decades and the first manifestation of disease  
 
may be overwhelming, if not fatal, hence non-invasive ultrasonographic  
 
measurement of IMT can be of  great value in screening for such asymptomatic patients.  
 
Preventing atherosclerosis and its progression remains a central goal in medicine (13). 
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 In view of the high prevalence of CAD in our society and the fact that simple methods  
 
such as IMT measurement may detect atherosclerosis in its nascence and help  
 
prevent fatal events; this study was designed to assess the value of carotid IMT in 
 
predicting the risk of CAD. The objective of this study is to evaluate coronary  
 
atherosclerosis in type 2 diabetic subjects and measure their common carotid IMT,  
 
and to assess the relationship between the two parameters. 
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REVIEW OF LITERATURE 
 
 
 
Definition and Demographics 
 
 
ATHEROSCLEROSIS  
 
Atherosclerosis is a multifactorial and dynamic process. One of its feature is the  
 
presence of fatty streaks along the vessel wall leading to build-up of plaques on  
 
the wall of arteries, which leads to reduction in caliber of vessels. Coronary artery  
 
disease (CAD) in India is reaching alarming and epidemic proportions (15,16). 
 
 
DIABETES  
 
India is frequently referred to as the diabetic capital of the world. Diabetes  
 
mellitus is widely prevalent in our country and its incidence is rising in alarming  
 
proportions.  
 
According to the Diabetes Atlas published by the International Diabetes Federation   
(IDF), there are an estimated 40 million persons with diabetes in India in 2007 and this 
number is predicted to rise to almost 70 million people in 2025 by which time every fifth 
diabetic subject in the world would be an Indian.  
The real burden of the disease is however due to its micro and macro vascular 
complications which lead to increased morbidity and mortality. Atherosclerotic vascular 
diseases, particularly Coronary artery diseases (CAD), are leading causes of morbidity and 
mortality amongst diabetics.  
 
CORONARY ARTERY DISEASE 
CAD causes more deaths and disability and incurs greater economic costs than any other 
illness in the developed world. Obesity, insulin resistance, and type 2 diabetes mellitus are 
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increasing and are powerful risk factors for CAD. With urbanization in the developing world, 
the prevalence of risk factors for CAD is increasing rapidly in these regions such that a 
majority of the global burden of CAD is now occurring in low-income and middle-income 
countries. Population subgroups that appear to be particularly affected are men in South 
Asian countries, especially India. Given the projection of large increases in CAD throughout 
the world, CAD is likely to become the most common cause of death worldwide by 2020. 
Pathogenesis 
ATHEROSCLEROSIS  (40) 
Atherosclerosis remains the major cause of death and premature disability in developed
societies. Moreover, current predictions estimate that by the year 2020 cardiovascular
diseases, notably atherosclerosis, will become the leading global cause of total disease 
burden. 
Initiation of Atherosclerosis 
An integrated view of experimental results in animals and studies of human atherosclerosis
suggests that the "fatty streak" represents the initial lesion of atherosclerosis. These early
lesions most often seem to arise from focal increases in the content of lipoproteins within 
regions of the intima. This accumulation of lipoprotein particles may not result simply from
an increased permeability, or "leakiness," of the overlying endothelium . Rather, these 
lipoproteins may collect in the intima of arteries because they bind to constituents of the
extracellular matrix, increasing the residence time of the lipid-rich particles within the arterial 
wall. 
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Leukocyte Recruitment 
Accumulation of leukocytes characterizes the formation of early atherosclerotic lesions. 
Thus, from its very inception, atherogenesis involves elements of inflammation, a process
that now provides a unifying theme in the pathogenesis of this disease. The inflammatory cell
types typically found in the evolving atheroma include monocyte-derived macrophages and 
lymphocytes. A number of adhesion molecules or receptors for leukocytes expressed on the
surface of the arterial endothelial cell likely participate in the recruitment of leukocytes to the
nascent atheroma. Constituents of oxidatively modified low-density lipoprotein (LDL) can 
augment expression of leukocyte adhesion molecules. Once captured on the surface of the
arterial endothelial cell by adhesion receptors, the monocytes and lymphocytes penetrate the
endothelial layer and take up residence in the intima.  
Foam Cell Formation 
Once resident within the intima, the mononuclear phagocytes mature into macrophages and
become lipid-laden foam cells, a conversion that requires the uptake of lipoprotein particles
by receptor-mediated endocytosis. 
Atheroma Evolution and Complications 
Although the fatty streak commonly precedes the development of a more advanced
atherosclerotic plaque, not all fatty streaks progress to form complex atheromata. By
ingesting lipids from the extracellular space, the mononuclear phagocytes bearing such
scavenger receptors may remove lipoproteins from the developing lesion. Some lipid-laden 
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macrophages may leave the artery wall, exporting lipid in the process. Lipid accumulation,
and hence propensity to form atheroma, ensues if the amount of lipid entering the artery wall
exceeds that removed by mononuclear phagocytes or other pathways. 
The arrival of smooth-muscle cells and their elaboration of extracellular matrix probably 
provides a critical transition, yielding a fibrofatty lesion in place of a simple accumulation of 
macrophage-derived foam cells. Transforming growth factor beta, among other mediators, 
potently stimulates interstitial collagen production by smooth-muscle cells. These mediators 
hasten transformation of the fatty streak into a more fibrous smooth-muscle cell and 
extracellular matrix-rich lesion. 
 
 Calcification 
As they advance, atherosclerotic plaques also accumulate calcium. Proteins usually found in 
bone also localize in atherosclerotic lesions, e.g., osteocalcin, osteopontin, and bone
morphogenetic proteins.  
Plaque Instability and Rupture 
Postmortem studies afford considerable insight into the microanatomic substrate underlying
the "instability" of plaques that do not cause critical stenoses. A superficial erosion of the 
endothelium or a frank plaque rupture or fissure usually produces the thrombus that causes
episodes of unstable angina pectoris or the occlusive and relatively persistent thrombus that
causes acute myocardial infarction. In the case of carotid atheromata, a deeper ulceration that
provides a nidus for formation of platelet thrombi may cause transient cerebral ischemic
attacks. 
8 
 
 
Prevention and Treatment 
The Concept of Atherosclerotic Risk Factors 
The systematic study of risk factors for atherosclerosis emerged from a coalescence of
experimental results as well as cross-sectional and ultimately longitudinal studies in humans.
The prospective, community-based Framingham Heart Study provided rigorous support for 
the concept that hypercholesterolemia, hypertension, and other factors correlated with
cardiovascular risk. Similar observational studies performed worldwide bolstered the concept
of "risk factors" for cardiovascular disease. 
From a practical viewpoint, the cardiovascular risk factors that have emerged from such
studies fall into two categories: those modifiable by lifestyle and/or pharmacotherapy and
those such as age and gender that are immutable.. 
Major Risk Factors (Exclusive of LDL Cholesterol) that Modify LDL Goals (40) 
  
Cigarette smoking 
Hypertension (BP 140/90 mmHg or on antihypertensive medication) 
Low HDL cholesterola [<1.0 mmol/L (<40 mg/dL)] 
Diabetes mellitus  
Family history of premature CHD 
  CHD in male first-degree relative <55 years 
  CHD in female first-degree relative <65 years 
Age (men 45 years; women 55 years) 
Lifestyle risk factors 
  Obesity (BMI 30 kg/m2) 
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  Physical inactivity 
  Atherogenic diet 
Emerging risk factors 
  Lipoprotein(a) 
  Homocysteine 
  Prothrombotic factors 
  Proinflammatory factors 
  Impaired fasting glucose 
  Subclinical atherogenesis  
 
  
 
 
ISCHEMIC HEART DISEASE 
Ischemic heart disease (IHD) is a condition in which there is an inadequate supply of blood
and oxygen to a portion of the myocardium; it typically occurs when there is an imbalance 
between myocardial oxygen supply and demand. The most common cause of myocardial
ischemia is atherosclerotic disease of an epicardial coronary artery (or arteries) sufficient to
cause a regional reduction in myocardial blood flow and inadequate perfusion of the 
myocardium supplied by the involved coronary artery. 
Pathophysiology 
Central to an understanding of the pathophysiology of myocardial ischemia is the concept of
myocardial supply and demand. Under normal conditions, for any given level of a demand 
for oxygen, the myocardium will be supplied with oxygen-rich blood to prevent 
underperfusion of myocytes and the subsequent development of ischemia and infarction. The
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major determinants of myocardial oxygen demand (MVO2) are heart rate, myocardial 
contractility, and myocardial wall tension (stress). An adequate supply of oxygen to the
myocardium requires a satisfactory level of oxygen-carrying capacity of the blood 
(determined by the inspired level of oxygen, pulmonary function, and hemoglobin 
concentration and function) and an adequate level of coronary blood flow. Blood flows
through the coronary arteries in a phasic fashion, with the majority occurring during diastole.
About 75% of the total coronary resistance to flow occurs across three sets of arteries: (1) 
large epicardial arteries (Resistance 1 = R1), (2) prearteriolar vessels (R2), and (3) arteriolar 
and intramyocardial capillary vessels (R3). In the absence of significant flow-limiting 
atherosclerotic obstructions, R1 is trivial; the major determinant of coronary resistance is
found in R2 and R3. 
By reducing the lumen of the coronary arteries, atherosclerosis limits appropriate increases in
perfusion when the demand for flow is augmented, as occurs during exertion or excitement. 
When the luminal reduction is severe, myocardial perfusion in the basal state is reduced. 
 
Asymptomatic versus Symptomatic IHD 
According to population studies, ~25% of patients who survive acute MI may not come to
medical attention, and these patients carry the same adverse prognosis as those who present
with the classic clinical picture of acute MI. Sudden death may be unheralded and is a 
common presenting manifestation of IHD. 
Patients with IHD can also present with cardiomegaly and heart failure secondary to ischemic 
damage of the LV myocardium that may have caused no symptoms prior to the development
of heart failure; this condition is referred to as ischemic cardiomyopathy. In contrast to the 
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asymptomatic phase of IHD, the symptomatic phase is characterized by chest discomfort due 
to either angina pectoris or acute MI. Having entered the symptomatic phase, the patient may
exhibit a stable or progressive course, revert to the asymptomatic stage, or die suddenly. 
 
Diagnosis : 
Although the diagnosis of IHD can be made with a high degree of confidence from the
clinical examination, a number of simple laboratory tests can be helpful. The urine should be
examined for evidence of diabetes mellitus and renal disease (including microalbuminuria)
since these conditions accelerate atherosclerosis. Similarly, examination of the blood should
include measurements of lipids (cholesterol—total, LDL, HDL—and triglycerides), glucose, 
creatinine, hematocrit, and, if indicated based on the physical examination, thyroid function. 
A chest x-ray is important as it may show the consequences of IHD, i.e., cardiac enlargement,
ventricular aneurysm, or signs of heart failure. These signs can support the diagnosis of IHD
and are important in assessing the degree of cardiac damage. 
Electrocardiogram 
A 12-lead ECG recorded at rest may be normal in patients with typical angina pectoris, but
there may also be signs of an old myocardial infarction. Although repolarization 
abnormalities—i.e., ST-segment and T-wave changes—as well as LV hypertrophy and 
intraventricular conduction disturbances are suggestive of IHD, they are nonspecific since
they can also occur in pericardial, myocardial, and valvular heart disease or, in the case of the
former, transiently with anxiety, changes in posture, drugs, or esophageal disease. Dynamic 
ST-segment and T-wave changes that accompany episodes of angina pectoris and disappear
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thereafter are more specific. 
Stress Testing (36) - Electrocardiographic stress test 
The most widely used test for both the diagnosis of IHD and estimating the prognosis
involves recording the 12-lead ECG before, during, and after exercise, usually on a treadmill. 
The test consists of a standardized incremental increase in external workload  while the
symptoms, ECG, and arm blood pressure are monitored. Performance is usually symptom-
limited, and the test is discontinued upon evidence of chest discomfort, severe shortness of
breath, dizziness, severe fatigue, ST-segment depression >0.2 mV (2 mm), a fall in systolic
blood pressure >10 mmHg, or the development of a ventricular tachyarrhythmia. This test
seeks to discover any limitation in exercise performance, to detect typical ECG signs of
myocardial ischemia, and to establish their relationship to chest discomfort. The ischemic ST-
segment response is generally defined as flat or downsloping depression of the ST segment
>0.1 mV below baseline (i.e., the PR segment) and lasting longer than 0.08 s. Upsloping or 
junctional ST-segment changes are not considered characteristic of ischemia and do not 
constitute a positive test. Although T-wave abnormalities, conduction disturbances, and 
ventricular arrhythmias that develop during exercise should be noted, they are also not
diagnostic. Negative exercise tests in which the target heart rate (85% of maximal predicted 
heart rate for age and sex) is not achieved are considered to be nondiagnostic. 
 
 
 
When interpreting ECG stress tests, the probability that coronary artery disease (CAD) exists
in the patient or population under study (i.e., pretest probability) should be considered. 
13 
 
Overall, false-positive or false-negative results occur in one-third of cases. However, a 
positive result on exercise indicates that the likelihood of CAD is 98% in males >50 years
with a history of typical angina pectoris and who develop chest discomfort during the test.
The likelihood decreases if the patient has atypical or no chest pain by during the test. 
The incidence of false-positive tests is significantly increased in patients with low
probabilities of IHD, such as asymptomatic men under the age of 40 or in premenopausal
women with no risk factors for premature atherosclerosis. It is also increased in patients
taking cardioactive drugs, such as digitalis and antiarrhythmic agents, or in those with
intraventricular conduction disturbances, resting ST-segment and T-wave abnormalities, 
ventricular hypertrophy, or abnormal serum potassium levels. Obstructive disease limited to
the circumflex coronary artery may result in a false-negative stress test since the lateral 
portion of the heart which this vessel supplies is not well represented on the surface 12-lead 
ECG. Since the overall sensitivity of exercise stress electrocardiography is only ~75%, a
negative result does not exclude CAD, although it makes the likelihood of three-vessel or left 
main CAD extremely unlikely. 
Contraindications to exercise stress testing include rest angina within 48 h, unstable rhythm,
severe aortic stenosis, acute myocarditis, uncontrolled heart failure, severe pulmonary
hypertension, and active infective endocarditis. 
Cardiac Imaging 
 When the resting ECG is abnormal (e.g., preexcitation syndrome, >1 mm of resting ST-
segment depression, left bundle branch block, paced ventricular rhythm), information gained
from an exercise test can be enhanced by stress myocardial radionuclide perfusion imaging
after the intravenous administration of thallium 201 or technetium 99m (99mTc) sestamibi 
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during exercise (or a pharmacologic) stress.   
Two-dimensional echocardiography can assess both global and regional wall motion 
abnormalities of the left ventricle due to MI or persistent ischemia. Stress (exercise or
dobutamine) echocardiography may cause the emergence of regions of akinesis or dyskinesis
not present at rest. Stress echocardiography, like stress myocardial perfusion imaging, is 
more sensitive than exercise electrocardiography in the diagnosis of IHD.  
Atherosclerotic plaques become progressively calcified over time, and coronary calcification
in general increases with age. For this reason, methods for detecting coronary calcium have 
been developed as a measure of the presence of coronary atherosclerosis. Coronary calcium
detected by these imaging techniques is quantified using the Agatston score most commonly,
which is based on the area and density of calcification. Although the diagnostic accuracy of
this imaging method is high (sensitivity, 90–94%; specificity, 95–97%; negative predictive 
value, 93–99%), its prognostic utility and its role in the evaluative algorithm of patients with
stable angina pectoris have not yet been defined. 
Coronary Arteriography 
This diagnostic method outlines the lumina of the coronary arteries and can be used to detect
or exclude serious coronary obstruction. However, coronary arteriography provides no
information regarding the arterial wall, and severe atherosclerosis that does not encroach on
the lumen may go undetected. Of note, atherosclerotic plaques characteristically grow
progressively in the intima and media of an epicardial coronary artery, at first without 
encroaching on the lumen, causing an outward bulging of the artery—a process referred to as 
negative remodeling.Later in the course of the disease, further growth causes luminal
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narrowing. 
Prognosis of  IHD 
The principal prognostic indicators in patients known to have IHD are age, the functional 
state of the left ventricle, the location(s) and severity of coronary artery narrowing, and the
severity or activity of myocardial ischemia. Angina pectoris of recent onset, unstable 
angina(40) , early  postmyocardial infarction angina, and angina that is unresponsive or poorly
responsive to medical therapy or is accompanied by symptoms of congestive heart failure all
indicate an increased risk for adverse coronary events. The same is true for the physical signs
of heart failure, episodes of pulmonary edema, transient third heart sounds, or mitral
regurgitation, and for echocardiographic or radioisotopic (or roentgenographic) evidence of
cardiac enlargement and reduced (<0.40) ejection fraction.  
Most importantly, any of the following signs during noninvasive testing indicate a high risk
for coronary events: inability to exercise for 6 min, i.e., stage II (Bruce protocol) of the
exercise test; a strongly positive exercise test showing onset of myocardial ischemia at low 
workloads (0.1 mV ST-segment depression before completion of stage II; 0.2 mV ST
depression at any stage; ST depression for >5 min following the cessation of exercise; a
decline in systolic pressure >10 mmHg during exercise; the development of ventricular 
tachyarrhythmias during exercise); the development of large or multiple perfusion defects or
increased lung uptake during stress radioisotope perfusion imaging; and a decrease in LV
ejection fraction (LVEF) during exercise on radionuclide ventriculography or during stress 
echocardiography. Conversely, patients who can complete stage III of the Bruce exercise
protocol and have a normal stress perfusion scan or negative stress echocardiographic
evaluation are at very low risk of future coronary events. 
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                The greater the number and severity of risk factors for coronary atherosclerosis
[advanced age (>75 years), diabetes, morbid obesity, accompanying peripheral and/or
cerebrovascular disease, previous MI], the worse the prognosis of the angina patient. 
Evidence exists that elevated levels of  increased carotid intimal thickening on ultrasound 
examination indicate an increased risk of coronary events.  
Stable Angina Pectoris: Treatment (37) 
The management plan should include the following components: (1) explanation of the 
problem and reassurance about the ability to formulate a treatment plan, (2) identification and
treatment of aggravating conditions, (3) recommendations for adaptation of activity as
needed, (4) treatment of risk factors that will decrease the occurrence of adverse coronary 
outcomes, (5) drug therapy for angina, and (6) consideration of revascularization (38) with 
either Percutaneous coronary intervention (39) or Coronary artery bypass grafting. 
 
 
 
 
 
 
  
 
Asymptomatic (Silent) Ischemia 
Obstructive CAD, acute MI, and transient myocardial ischemia are frequently asymptomatic.
During continuous ambulatory ECG monitoring, the majority of ambulatory patients with
typical chronic stable angina are found to have objective evidence of myocardial ischemia 
(ST-segment depression) during episodes of chest discomfort while they are active outside
the hospital, but many of these patients have more frequent episodes of asymptomatic
ischemia. In addition, there is a large (but as yet unknown) number of totally asymptomatic 
persons with severe coronary atherosclerosis who exhibit ST-segment changes during 
17 
 
activity.  
Frequent episodes of ischemia (symptomatic and asymptomatic) during daily life appear to be
associated with an increased likelihood of adverse coronary events (death and MI). In
addition, patients with asymptomatic ischemia after suffering a myocardial infarction are at
greater risk for a second coronary event. The widespread use of exercise ECG during routine
examinations has also identified some of these heretofore unrecognized patients with
asymptomatic CAD. Longitudinal studies have demonstrated an increased incidence of
coronary events in asymptomatic patients with positive exercise tests (44-47) . 
Asymptomatic Ischemia: Treatment (37) 
The management of patients with asymptomatic ischemia must be individualized. Thus, the
physician should consider the following: (1) the degree of positivity of the stress test,
particularly the stage of exercise at which ECG signs of ischemia appear, the magnitude and 
number of the ischemic zones of myocardium on imaging, and the change in LVEF which
occurs on radionuclide ventriculography or echocardiography during ischemia and/or during
exercise; (2) the ECG leads showing a positive response, with changes in the anterior 
precordial leads indicating a less favorable prognosis than changes in the inferior leads; and
(3) the patient's age, occupation, and general medical condition. 
The treatment of risk factors, particularly lipid lowering as described above, and the use of 
aspirin, beta blockers, and statins have been shown to reduce events and improve outcomes in
asymptomatic as well as symptomatic patients with ischemia and proven CAD. While the
incidence of asymptomatic ischemia can be reduced by treatment with beta blockers, calcium 
channel blockers, and long-acting nitrates, it is not clear whether this is necessary or desirable
in patients who have not suffered a myocardial infarction.  
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DIABETES MELLITUS 
 
Diabetes mellitus (DM) refers to a group of metabolic disorders which have a 
common denominator namely hyperglycemia. Factors contributing to hyperglycemia include 
reduced insulin secretion, decreased glucose utilization, and increased glucose production. 
The metabolic dysregulation associated with DM causes secondary pathophysiologic changes 
in multiple organ systems that impose a tremendous burden on the individual with diabetes 
and on the health care system.(40) 
 
 
Classification 
DM is classified on the basis of the pathogenic process that leads to hyperglycemia. 
The two broad categories of DM are designated type 1 and type 2.  
 - Type 1 diabetes is the result of complete or near-total insulin deficiency.  
- Type 2 DM is a heterogeneous group of disorders characterized by variable degrees of 
insulin resistance, impaired insulin secretion, and increased glucose production. Type 2 DM 
is preceded by a period of abnormal glucose homeostasis classified as impaired fasting 
glucose (IFG) or impaired glucose tolerance (IGT). 
Pathophysiology 
Type 2 DM is characterized by impaired insulin secretion, insulin resistance, 
excessive hepatic glucose production, and abnormal fat metabolism. Obesity, particularly 
visceral or central (as evidenced by the hip-waist ratio), is very common in type 2 DM. In the 
early stages of the disorder, glucose tolerance remains near-normal, despite insulin resistance, 
because the pancreatic beta cells compensate by increasing insulin output. As insulin 
resistance and compensatory hyperinsulinemia progress, the pancreatic islets in certain 
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individuals are unable to sustain the hyperinsulinemic state. IGT, characterized by elevations 
in postprandial glucose, then develops. A further decline in insulin secretion and an increase 
in hepatic glucose production lead to overt diabetes with fasting hyperglycemia. Ultimately, 
beta cell failure may ensue. 
 
 
Chronic Complications of DM 
The chronic complications of DM affect many organ systems and are responsible for the
majority of morbidity and mortality associated with the disease. Chronic complications can 
be divided into vascular and nonvascular complications. The vascular complications of DM 
are further subdivided into microvascular (retinopathy, neuropathy, nephropathy) and
macrovascular complications [coronary artery disease (CAD), peripheral arterial disease 
(PAD), cerebrovascular disease].  
 
 
 
The microvascular complications of both type 1 and type 2 DM result from chronic
hyperglycemia. Large, randomized clinical trials of individuals with type 1 or type 2 DM
have conclusively demonstrated that a reduction in chronic hyperglycemia prevents or delays
retinopathy, neuropathy, and nephropathy. 
Evidence implicating a causative role for chronic hyperglycemia in the development of
macrovascular complications is less conclusive. However, coronary heart disease events and 
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mortality are two to four times greater in patients with type 2 DM. These events correlate
with fasting and postprandial plasma glucose levels as well as with the A1C. Other factors
(dyslipidemia and hypertension) also play important roles in macrovascular complications. 
Mechanism of Complications 
Although chronic hyperglycemia is an important etiologic factor leading to complications of
DM, the mechanism(s) by which it leads to such diverse cellular and organ dysfunction is 
unknown. Four prominent theories, which are not mutually exclusive, have been proposed to
explain how hyperglycemia might lead to the chronic complications of DM. One theory is 
that increased intracellular glucose leads to the formation of advanced glycosylation end 
products (AGEs) via the nonenzymatic glycosylation of intra- and extracellular proteins, 
sorbitol pathway, phosphokinase C pathway and hexosaminase pathway being the other three
postulates.  
CAROTID INTIMA MEDIA THICKNESS 
Two decades ago investigators showed that the thickness of the carotid wall (intima and 
media layer taken together) measured  ultrasonographically was associated with the presence
and extent of atherosclerosis of the aorta (5,41). Due to the limited resolution of the ultrasound 
equipment the intima cannot be differentiated from the media. Nonetheless, several
randomized and epidemiological studies clearly proved the value of the CIMT as a marker of 
CVD risk. An increased CIMT has been associated with risk of MI and CVA in the elderly (> 
65 years) (14) as well as younger age groups. Furthermore, it was recently shown that CIMT
adds incremental prognostic information to traditional risk factors for the prediction of 
coronary events in asymptomatic patients with type 2 diabetes. Of note, there is only a 
modest relationship between CIMT and obstructive CAD in non-diabetic, as well as diabetic 
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subjects (13) . This clearly suggests that CIMT is a marker of atherosclerosis burden rather
than a surrogate for obstructive CAD. 
Increased CIMT in diabetes has been associated with risk factors for atherosclerosis such as 
high serum triglyceride levels and low total/HDL cholesterol ratio,LDL (42,43) , age, BMI, 
Lp(a), microalbuminuria, as well as endothelial dysfunction and low grade inflammation. 
Insulin resistance alone in the absence of clinical diabetes has been associated with an
increased CIMT. Sequential CIMT measurements have demonstrated that diabetes is an 
independent predictor of CIMT progression (9) . 
                            Furthermore, CIMT appears to progress faster in diabetic patients than in all 
other patients. In IRAS, the investigators enrolled 1,192 men and women with normal or IGT 
and fulminant type 2 diabetes. Participants with diabetes showed the fastest CIMT
progression during the five-year follow- up. In non-diabetic subjects, common and internal 
carotid artery CIMT progressed by 3.8 and 17.7 µm/year, respectively and no significant 
difference was noted between patients with normal glucose tolerance or IGT. Diabetic 
subjects showed a two-fold greater progression of both common and internal carotid artery 
CIMT. Glycaemic control (both fasting glucose levels and HbA1C) were at least in part 
responsible for such accelerated progression. 
                         B-mode ultrasound is a relatively inexpensive and safe technique that can 
noninvasively visualize the vessel lumen. B-mode ultrasound has been validated for 
measuring intima-media thickness (IMT) in several independent laboratories, and its 
reliability has been established in single- and multicenter studies. Current ultrasound 
instrumentation with transducers 4-8 MHz are most capable of identifying the 2 arterial 
interfaces (lumen-intima and media-adventitia) necessary for measuring IMT. The screening
examination is performed bilaterally on the extracranial carotid artery segments. These 
segments are the distal straight 1 cm of the common carotid arteries, the carotid bifurcations, 
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and the proximal 1 cm of the internal carotid arteries. Circumferential longitudinal scans can 
identify IMTs  on the near and far walls of each segment (total of 6 walls per side). The 
actual thickness of each lesion is measured with ultrasound instrument calipers. IMT is an
operational measurement definition of a single characteristic of atherosclerosis based on 
considerable information documenting that both the intima and media are involved in
atherogenesis and the anatomical progression of lesions. 
                     Common carotid IMT has been associated with prevalent cardiovascular disease
in cross-sectional studies (45–47) . Furthermore, various published studies found that carotid 
IMT measurement is a viable predictor of the presence of coronary atherosclerosis and its
clinical sequelae (44,45-47) . Thus, carotid IMT defined by noninvasive B-mode ultrasound has 
been shown to be an independent risk factor for CAD events and stroke. The strongest data
relating IMT measurement with incident cardiovascular events derive from the 
Atherosclerosis Risk in Communities (ARIC) Study (12) .   
                  Several clinical intervention or prevention trials have illustrated the ability of 
carotid B-mode ultrasound imaging to monitor changes in IMT over time. Although serial
measurements can be standardized in well-controlled research settings, protocols for 
sonographers to monitor IMT over time in a valid and reliable manner have not yet been
implemented in clinical practice environments.  
To assess the regression or progression of atherosclerosis in intervention trials. IMT 
measurement is  the best-established, and longitudinal studies have presented the regression 
of atherosclerosis by lipidlowering with statins .This was evident from the  trials conducted 
by  Furberg CD  et al. Effects of lovastatin on early carotid atherosclerosis and cardiovascular 
events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. 
Circulation 1994; 90:1679–87  and Groot Eet al ; Effects of pravastatin on progression and 
regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: 
23 
 
a report form the Regression Growth Evaluation Statin Study. Am J Cardiol 1995; 76:40–6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
 
 
 
1. To find out the prevalence of  coronary artery disease in asymptomatic 
 
type 2 diabetes  mellitus patients by treadmill test. 
 
 
2. To estimate subclinical atherosclerosis in patients with type 2 diabetes 
 
mellitus by measuring the carotid intima media thickness. 
 
 
3. To find the association between carotid intima media thickness 
 
and  coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. 
 
 
4. To study the association of age, sex, body mass index, smoking, alcohol, duration of 
diabetes, hypertension, fasting hyperglycemia, serum total cholesterol, diabetic 
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retinopathy,  nephropathy and peripheral vascular disease with the carotid intima 
media thickness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 
Setting:  
The study was conducted on type 2 diabetic patients attending the out patient  
 
department of  Government Rajaji Hospital, Madurai. 
 
Design of study:  The study was a cross sectional  case-control analytical study. 
 
 
Period of study: The study was conducted from June 2007 to November 2008. 
 
 
Ethical committee approval:  Approval from the hospital ethical committee was obtained.  
 
Consent : Informed consent was obtained from the subjects studied. 
 
Criteria for selection of subjects: Rigid criteria were adopted for inclusion and exclusion of  
 
cases and controls for the present study. The details are furnished below. 
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Inclusion criteria:  
 
Asymptomatic individuals attending the outpatient department of medicine and  diabetology  
 
diagnosed with type 2 diabetes mellitus according to ADA 2007 criteria were included in the  
 
study if they met the following inclusion criteria.   
 
1) no episodes of  ketoacidosis and absence of  ketonuria, 
 
 2) diagnosis of diabetes after 30 years of age,  
 
3) insulin therapy (if any) started after at least 5 years after diagnosis and 
 
5) absence of acute stage or signs and symptoms of CHD / cerebral vascular disease  
 
    after careful evaluation of clinical records.  
 
Type 2 diabetes mellitus cases with evidence of previous MI either with ECG evidence of  
 
STEMI or echocardiography showing regional wall motion abnormality were also included to  
 
avoid selection bias and to act as positive controls in order to assess the strength of  
 
association. 
 
              The determination of  type 2 diabetes was based on ADA 2007 criteria, which  
 
defines the diagnosis of Diabetes Mellitus as follows: 
 
1. Symptoms of diabetes plus random blood glucose>200mg/dl    (or) 
 
2.  Fasting plasma glucose>126mg/dl    (or) 
 
3.  Two-hour plasma glucose>200mg/dl during an oral GTT. 
 
Exclusion criteria:  
 
1. Those having acute metabolic complications like hypoglycemia, diabetic ketoacidosis, 
hyperosmolar hyperglycaemic state, cerebrovascular accidents, acute infections, 
inherited disorders of lipid and lipoprotein metabolism and/or family history of such 
disorders and deranged liver functions were excluded. 
2. Patients on lipid lowering treatment 
3. Previous history of CABG or PCI intervention. 
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4. Contraindications to exercise stress testing which include rest angina within 48 h, 
unstable rhythm, severe aortic stenosis, acute myocarditis, uncontrolled heart failure, 
severe pulmonary hypertension, and active infective endocarditis.  
Subjects:  Thus a total of 50 cases that satisfied the inclusion and exclusion criteria stated  
above were taken up for the study. 15 cases of type 2 diabetics with MI served as positive 
controls to provide corroborative evidence of the strength of association and to eliminate 
selection bias. 
Controls : Fifteen (10 males and 5 females) age, sex and BMI matched non-diabetic  
 
subjects with no evidence of cardiovascular, cerebrovascular or peripheral vascular disease or  
 
their risk factors were recruited as controls. 
 
Study protocol:  Patients attending the outpatient department of diabetology or medicine in  
 
Government Rajaji Hospital were the study group. A well designed proforma was used to  
 
collect the demographic and clinical details of the patients. 
Collaborating departments: 
 
 Department of Medicine, Madurai Medical College, Madurai 
 
Department of Cardiology, Madurai Medical College, Madurai 
 
Department of Diabetology, Madurai Medical College, Madurai 
 
Department of Vascular Surgery, Madurai Medical College, Madurai. 
 
 
METHODS:  Selected sociodemographic, clinical and laboratory data were collected from  
 
both the cases and controls and were recorded in a pro forma. 
 
Socio demographic data comprised of: 
- age 
- sex 
- locality 
- occupation 
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Clinical data comprised of: 
              -    History of Diabetes, hypertension 
              -    History of smoking, alcohol 
              -    Height, weight and BMI 
              -    General and systemic examination 
              -    Fundus examination 
              -    Examination of peripheral pulses and BP recording in all 4 limbs with 
                  Ankle-Brachial Index (ABI) calculated from the BP values. 
Laboratory data included: 
- Urine - albumin, deposits, Sugar 
- Fasting Blood Sugar 
- Blood Urea 
- Serum Creatinine 
- Fasting Serum Total Cholesterol 
- ECG 
 
 
Imaging studies 
- TMT 
- Echocardiography 
- CAROTID INTIMA MEDIA THICKNESS by Doppler 
 
 
 65 consecutive type 2 diabetic patients (diagnosed by the World Health Organization 
criteria) among the outpatients attending departments of  medicine and diabetology were 
subjected to detailed history, physical examination, BP recording in all 4 limbs, examination 
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of all peripheral pulses, height, weight and calculated BMI(weight in kg / height in metre 
square).Baseline laboratory data, resting 12-lead ECG, TMT, Echocardiography, and 
CIMT measurement were collated for each patient. Fasting blood sample was obtained, and 
measurement of serum total cholesterol, serum creatinine, blood urea, and blood sugar was 
made by standard laboratory techniques. A single morning urine sample was obtained and 
was tested for the presence of albumin by heat coagulation method. 
                       Blood pressure was measured with a standard mercury sphygmomanometer 
after the subject had been seated for at least 5 min. Hypertension was defined as a systolic 
blood pressure >140 mmHg, a diastolic blood pressure >90 mmHg, and/or the use of 
antihypertensive medication in accordance with JNC VII criteria. 
                       CAD was diagnosed based on combinations of symptoms, resting 
electrocardiogram (ECG) changes, positive TMT result and echocardiographic evidence of  
regional wall motion abnormality (RWMA) suggestive of CAD.  
                      Screening for silent myocardial ischemia was performed on the remaining 
patients. Exercise ECG  in the form of Tread Mill Testing (TMT) was the choice for 
screening method. Modified Bruce Protocol was performed in 50 randomly selected type 2 
diabetic patients.  
                        Hyperlipidemia was considered present when the patient had a serum total 
cholesterol level >200 mg/dl. 
                        Ankle-Brachial Index (ABI) was considered to be positive if  the patient had 
ratio of systolic BP in ankle to that of  the arm less than 1 in either of the limbs.Peripheral 
vascular disease (PVD) was considered to be positive if any of the cases had showed a 
positive ABI. 
                       The  criterion for diagnosis of diabetic retinopathy was the presence of at least 
one definite microaneurysm in any field of the eye. Briefly, level 10 represents no 
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retinopathy, levels 20–50 nonproliferative diabetic retinopathy, and level >60proliferative 
diabetic retinopathy.  
                      The presence of a positive albumin test in urinalysis was taken as evidence of 
diabetic nephropathy. 
Tread Mill Testing (TMT) : 
The most widely used test for both the diagnosis of IHD and estimating the prognosis 
involves recording the 12-lead ECG before, during, and after exercise, usually on a treadmill. 
The test consists of a standardized incremental increase in external workload ,while the 
symptoms, ECG, and arm blood pressure are monitored.  
 
Positive TMT result : 
The ischemic ST-segment response is generally defined as flat or downsloping depression of 
the ST segment >0.1 mV below baseline (i.e., the PR segment) and lasting longer than 0.08 s. 
 
 Negative TMT result : 
Upsloping or junctional ST-segment changes are not considered characteristic of ischemia 
and do not constitute a positive test. Negative exercise tests in which the target heart rate 
(85% of maximal predicted heart rate for age and sex) is not achieved are considered to be 
nondiagnostic.  
ECHOCARDIOGRAPHY : 
Two-dimensional echocardiography to assess both global and regional wall motion  
abnormalities of the left ventricle due to MI were taken as evidence of CAD. 
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Echocardiography was also done to rule out contraindications to exercise stress testing 
include severe aortic stenosis, acute myocarditis, uncontrolled heart failure, severe pulmonary 
hypertension, and active infective endocarditis. 
ASSESSMENT OF CAROTID INTIMA MEDIA THICKNESS : 
 
Ultrasonographic scanning of the carotid arteries was performed using WIPRO – Ge logic 
400 MD scanner with a linear transducer (midfrequency range 7.5–10 MHz).  The patient 
being in supine position and chest being elevated with a pillow and the head being turned to 
the opposite side of  the carotids examined. The probe was placed on the medial side of the 
sternocleidomastoid muscle to identify the carotid vessel and the carotid bulb was traced. 
Intima media thickness was assessed at about 1.0 cm proximal to the carotid bulb. The 
carotid wall shows parallel echogenic lines separated by a hypoechoic region (media). The 
inner line is the lumen – intima interface and the outer is the media – adventitia interface. 
Carotid IMT was defined as the distance from the leading edge of the first echogenic line to 
the leading edge of the second echogenic line on the scans. Carotid IMT was measured on 
both sides and the average value was taken as the mean CIMT.IMT value of more than 0.8 
mm is suggestive of significant atherosclerosis (53) . 
 
Conflict of interest:  There was no conflict of interest. 
 
Financial support:    Nil. 
 
Statistical analysis:  
The information collected regarding all the selected cases were recorded in a Master 
Chart in Microsoft Excel spreadsheet. Data analysis was done with the help of computer 
using Epidemiological Information Package (EPI 2002).  
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 Using this software, frequencies, percentages, means, standard deviations, chi square 
and  'p'  values were calculated. Kruskul Wallis chi-square  test was used to test the 
significance of difference between quantitative variables and Yate’s test for qualitative 
variables. A 'p' value less than 0.05 is taken to denote significant relationship. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            Observations and Results 
Profile of Total Cases studied : 
Majority of the patients were from in and around Madurai city. The total number of patients 
included in the study was 65. Fifteen controls were also included in the study for comparative 
analysis.  
Patients were divided into three groups : 
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GROUP I (NON-CAD) -  Type 2 diabetics who were screened for silent ischemia by 
TMT and echocardiography,  who showed negative results for 
CAD . 
GROUP II (CAD) -  Type 2 diabetics subclassified into those who showed evidence 
of CAD in the form of  either a positive TMT result (IHD) or 
echocardiographic evidence of RWMA  (MI). 
GROUP III (CONTROL) –  Age , sex and BMI matched non-diabetics 
 
Among the total of 65 Type 2 diabetes mellitus patients, 23 diabetic patients 
[Female (F)-5; Male (M)-18] had no evidence of CAD (Group-I), whereas 42 diabetic 
patients (F-9; M-33) had evidence of CAD (Group-II). Among the group II cases, 27 cases 
were asymptomatic (IHD) and the rest 15 were symptomatic (MI). 
Out of the 15 controls (Group-III), 10 were male and 5 were female. They had no 
evidence of diabetes or its complications after clinical and laboratory evaluation. 
  The age distribution of the patients is shown in table 1. 
 
 COMPARISON OF PARAMETERS IN THE THREE GROUPS 
Table 1 : Age distribution 
Group I Group II Group III 
Age group 
No % No % No % 
Less than 40 2 8.7 1 2.4 - - 
40-60 21 91.3 34 81 15 100 
>60 - - 7 16.7 - - 
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Total 23 100 42 100 15 100 
Mean 48.8 yrs 52.4 yrs 50.3 yrs 
SD 7.4 yrs 8 yrs 5.4 yrs 
‘p’ 0.2135  Not Significant 
 
The age of the patients in group I ranged from 33-60 years with a mean of 48.8+7.4 years, 
while that of group II ranged from 34-65 years with a mean of 50.3+5.4 years. The age of 
the controls ranged from 45 to 60 years with a mean age of 50.3+5.4 years.  Twenty  one  
patients in group I (91.3%) and thirty four patients in group II (81%) were in the age 
group of 40-60 years. 
The age groups of all the three groups were comparable and there was no 
statistical difference (p=0.2135). 
 
 
Table 2 : Sex Distribution 
Group I Group II Group III 
Sex 
No % No % No % 
Males 18 78.3 33 78.6 10 66.7 
Females 5 21.7 9 21.4 5 33.3 
Total 23 100 42 100 15 100 
 
It was observed that  there were 18 males and 5 females in Group I, 33 males and 
9 females in Group II, 10 males and 5 females in Group III. 
Table 3 : Duration of DM 
 
Group I Group II Group III 
Parameter 
No % No % No % 
Duration of DM 
<10 years 15 65.2 12 28.6 - - 
10-15 years 4 17.4 18 42.9 - - 
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Group I Group II Group III 
Parameter 
No % No % No % 
>15 years 4 17.4 12 28.6 - - 
 
 
Of the 23 cases in Group I, 65.2% of them had duration of DM <10 years compared  
 
to 28.6% in group II,17.4% had DM for 10-15years compared  to 42.9% in group II  
 
and 17.4% had DM for>15 years compared to 28.6% of cases in group II.   
 
 
Table 4:  Prevalence of Hypertension 
 
Group I Group II Group III 
Parameter 
No % No % No % 
Hypertension 
Present 5 21.7 21 50 - - 
Absent 18 78.3 21 50 15 100 
 
 
In our study, hypertension was present in 5 cases (21.7 %) in group I and 21 cases  
 
(50%) in group II. 
 
 
 
 
 
 
 
Table 5 : Prevalence of Smoking 
Group I Group II Group III 
Parameter 
No % No % No % 
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Group I Group II Group III 
Parameter 
No % No % No % 
Smoking among males 
Yes 7 38.9 19 45.5 5 33 
No 16 61.1 23 54.5 10 67 
 
The table shows that 38.9% of group I males and 45.5% of group II males were 
smokers. 
 
 
Table 6: Prevalence of Alcoholism 
Group I Group II Group III 
Parameter 
No % No % No % 
Alcoholism 
Yes 10 43.5 16 38.1 5 33 
No 13 56.5 26 61.9 10 67 
 
In our study ,26 cases (32.5%) in total were alcoholics, out of which 10 cases  
 
belonged to group I and 16 cases belonged to group II. All alcoholics were males. 
 
 
Table 7 :  BMI 
 
BMI Group I Group II Group III 
Mean 26.4 27.4 25.6 
SD 3.1 3.1 3.1 
‘P’ 0.1124  Not Significant 
 
The BMI of the three groups was comparable and there was no statistical  
difference (p=0.1124). 
 
Table 8:  Fasting Blood Sugar 
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FBS Group I Group II Group III 
Mean 185.0 193.2 94.2 
SD 42 49.3 12.9 
‘p’ 0.0001  Significant 
 
Mean fasting blood glucose was 185+ 42 mg/dl in group I compared to 193.2+49.3  
 
mg/dl in group II and 94.2+12.9 mg/dl in group III. 
 
The FBG of the three groups showed significant difference (p=0.0001), cases with  
 
CAD showing higher mean FBG values. 
 
 
 
Table 9: Total Cholesterol 
 
Total 
Cholesterol Group I Group II Group III 
Mean 193.8 214.6 180.1 
SD 32.2 32.6 21.3 
‘P’ 0.0008   Significant 
 
 
The fasting serum total cholesterol values in the three groups  had a mean  
 
of  193.8+32.2 mg/dl in group I, 214.6+32.6 mg/dl in group II and 180.1+21.3 mg/dl  
 
in group III respectively. 
 
There was statistically significant difference (p=0.0008) in the TC values  
 
between the three groups, diabetics with evidence of CAD having  
 
significantly higher prevalence of hypercholesterolemia compared to  
 
diabetics without CAD and non-diabetic controls.  
 
Table 10 : Prevalence of Retinopathy 
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Group I Group II Group III 
Parameter 
No % No % No % 
Retinopathy 
Yes 3 13 19 45.2 - - 
No 20 87 23 54.8 15 100 
 
In our study, retinopathy was present in 22 cases totally, out of which  3 cases (13%)   
were in group I and in 19 cases (45.2%) were in group II. 
 
 
 
Table 11 : Prevalence of Nephropathy 
Group I Group II Group III 
Parameter 
No % No % No % 
Nephropathy 
Yes 2 8.7 9 21.4 - - 
No 21 91.3 33 78.6 15 100 
 
Our study shows that,  11 cases (13.8% prevalence)  had evidence of diabetic 
nephropathy in total.  2 cases were in group I and the remaining 9 cases belonged to 
group II. 
 
 
 
Table 12 : Prevalence of PVD 
Group I Group II Group III 
Parameter 
No % No % No % 
PVD 
Yes 2 8.7 8 19 - - 
No 21 91.3 34 81 15 100 
 
The above table  from our study shows that there were 10 cases( 12.5% prevalence) 
of PVD in diabetics. Of this, 2 cases belonged to group I and 8 cases belong to group 
II. 
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Table 13 : Prevalence of  CAD 
 
Asymptomatic  
Diabetics Parameter 
No % 
CAD   
Positive (GroupII) 27 54 
Negative (Group I) 23 46 
 
Our study showed  54% prevalence of  CAD among  asymptomatic type 2 diabetics. 
 
 
Table 14:  Carotid Intima Media Thickness and Coronary Artery Disease 
 
CIMT Group I Group II Group III 
Mean 0.79 1.33 0.59 
SD 0.35 0.52 0.1 
 
 
Group I and Group III – ‘p’ value 0.0941  (Not significant) 
 
Group II and Group III – ‘p’ value  0.0001  (Significant) 
 
Group I and Group II – ‘p’ value 0.0001 (Significant) 
 
 
The mean value of CIMT  was 0.79+0.35 mm in group I, 1.33+0.52 mm in  
 
group II and 0.59+0.1 mm in group III respectively. The mean CIMT among  
 
diabetics was 1.06 +0.43mm. 
 
There was statistically significant  difference in CIMT between the CAD group with  
 
Non-CAD group and controls.  
 
There was no significant difference in CIMT value between Non-CAD group and  
 
controls. 
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Table 15 : CIMT in Asymptomatic Diabetic with CAD compared to MI cases 
 
       CIMT 
Parameter 
Mean SD 
              ‘p’ 
Asymptomatic 
CAD Group 1.22 0.5 
MI Group 1.53 0.51 
           0.0544  
    Not Significant 
 
  
 
      Table 16 : CIMT in Asymptomatic Diabetics with CAD compared to controls  
 
 
        CIMT 
 Parameter 
Mean SD 
             ‘p’ 
Asymptomatic 
CAD Group 1.22 0.5 
Controls 0.59 0.1 
             0.0001  
          Significant 
 
 
Mean CIMT  was high in diabetics with Asymptomatic CAD (1.22mm) and MI cases  
 
(1.53 mm).The difference was not statistically significant between the groups(p=0.0544). 
 
The results thus show that CIMT was associated with CAD in established MI cases as  
 
well as in asymptomatic diabetics.  
 
When compared to controls, mean CIMT was significantly associated with  
 
asymptomatic CAD group (p=0.0001). 
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RELATIONSHIP OF CIMT WITH OTHER PARAMETER IN THE 3 GROUPS 
 
 
Table 17 : Age and CIMT 
 
CIMT 
Group I Group II Group III 
Age 
group 
No SD No SD No SD 
<40 0.5 - 0.5 - - - 
40-60 0.82 0.35 1.3 0.54 0.59 0.1 
>60 - - 1.61 0.25 - - 
‘p’ 0.0979  Not Significant 
0.0032  
Significant - 
 
There  was significant difference in the mean CIMT when compared with age  
between group I (p=0.0979) and group II (p=0.0032). 
 
 
 
Table 18 : Sex and CIMT 
 
CIMT Value in Group 
Group I Group II Group III Sex 
No SD No SD No SD 
Males 0.83 0.36 1.35 0.52 0.58 0.1 
Female 0.66 0.27 1.26 0.57 0.62 0.11 
‘p’ 0.3089  Not Significant 
0.7234  
Not Significant 
0.6081  
Not Significant 
 
Mean CIMT values between males and females were 0.83 and 0.66mm in  
 
group I (p=0.3089),  1.35 and 1.26 mm in group II (p=0.7234),  0.58 and       
 
0.62mm in group III (p=0.6081) respectively. 
 
There was no significant difference in CIMT values between both sexes of the  
same group. 
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 Table 19  : Duration of DM  and CIMT 
 
CIMT 
Group I Group II Group III Duration of DM   
Mean S.D. Mean S.D. Mean S.D. 
< 10 yrs 0.64 0.18 0.88 0.44 - - 
10-15 yrs 0.85 0.39 1.38 0.37 - - 
>15yrs 1.3 0.36 1.7 0.5 - - 
‘p’ 0.0136  Significant 
0.0003  
Significant - 
 
 
From the table, it is evident that  CIMT was maximum in patients who had longer  
 
duration of DM in group I (p=0.0136) and group II  (p=0.0003). 
 
 
 
Table 20 : Hypertension  and CIMT 
 
CIMT 
Group I Group II Group III Hypertension   
Mean S.D. Mean S.D. Mean S.D. 
Present 1.12 0.46 1.61 0.46 - - 
Absent 0.7 0.25 1.05 0.43 0.59 0.1 
‘p’ 0.0237  Significant 
0.0032  
Significant - 
 
 
This table shows that CIMT is significantly associated with the prevalence of  
 
hypertension in diabetics belonging to the Non-CAD group (p=0.0237) and the CAD  
 
group (p=0.0032). 
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Table  21 : Smoking  and CIMT 
 
CIMT 
Group I Group II Group III Smoking 
Mean S.D. Mean S.D. Mean S.D. 
Yes 0.83 0.19 1.45 0.51 0.63 0.12 
No 0.69 0.39 0.86 0.52 0.61 0.1 
‘p’ 0.7611 Not significant 
0.01518 
Significant 
0.6341 
Not significant 
 
 
Our study shows that CIMT wass significantly associated with smoking in the CAD 
group (p=0.01518). 
 
Table  22 : Alcoholism  and CIMT 
 
CIMT 
Group I Group II Group III Alcoholism 
Mean S.D. Mean S.D. Mean S.D. 
Yes 0.75 0.28 1.46 0.49 0.64 0.12 
No 0.82 0.4 1.25 0.54 0.58 0.1 
‘p’ 0.95 Not significant 
0.1936 
Not significant 
0.834 
Not significant 
 
CIMT in alcoholics belonging to group I was 0.75 mm compared to 0.82 mm in non- 
 
alcoholics. The difference was not statisitically significant (p=0.95).  
 
CIMT in alcoholics belonging to group II was 1.46 mm compared to 1.25 mm in  
 
non- alcoholics in that group. The difference was again not statistically significant 
 
(p=0.1936). 
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Table 23 : Fasting Blood Sugar and CIMT 
 
CIMT for 
Group I Group II Group III FBS 
No SD No SD No SD 
Normal (<126) 0.63 0.06 0.97 0.66 0.59 0.1 
Abnormal (>126) 0.82 0.36 1.36 0.51 - - 
‘p’ 
 
0.579 
Not Significant 
 
0.0034  
 Significant - 
 
Group I & II – ‘p’ value  is 0.0046 
 
Mean CIMT for cases in CAD group showed a statistically significant association  
 
with fasting hyperglycemia (p=0.0046) compared to non-CAD group. 
 
 
 
 
 
Table 24 :Total Cholesterol and CIMT 
 
CIMT 
Group I Group II Group III Total Cholestrol 
No SD No SD No SD 
Normal (<200) 0.59 0.1 0.97 0.45 0.57 0.09 
Abnormal (>200) 1.1 0.37 1.6 0.4 0.7 0.1 
‘p’ 0.0016  Significant 
0.0002  
Significant 
0.0589  
Not significant 
 
 
CIMT showed a statistically significant association with the prevalence of 
hypercholesterolemia in group I (p=0.0016)and group II  (p=0.0002).   
 
CIMT was significantly associated with hypercholesterolemia in diabetics with 
stronger association in diabetics with CAD.  
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Table 25: Retinopathy and CIMT 
 
CIMT for 
Group I Group II Group III Retinopathy 
No SD No SD No SD 
Present 1.4 0.36 1.56 0.44 - - 
Absent 0.7 0.24 1.14 0.52 0.59 0.1 
‘p’ 
 
0.0097   
Significant 
 
0.0112   
Significant - 
 
 
CIMT  was significantly high with patients in group  I (p=0.0097) and group II  
 
(p=0.0112) who had diabetic retinopathy.The table shows that CIMT has a  
 
significant association with the prevalence of diabetic retinopathy. 
 
 
 
Table 26 : Nephropathy and CIMT 
 
CIMT for 
Group I Group II Group III Nephropathy 
No SD No SD No SD 
Present 1.55 0.35 1.76 0.31 - - 
Absent 0.72 0.25 1.22 0.51 0.59 0.1 
‘p’ 
 
0.0205  
Significant 
 
0.0081   
Significant - 
 
CIMT was higher in diabetics with nephropathy in group I and group II.                
 
The association was significant in group I (p=0.0205) and group II (p=0.0081). 
 
The result shows that CIMT was signifaicantly associated with the prevalence of 
nephropathy in diabetics. 
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Table 27: PVD and CIMT 
 
CIMT for 
Group I Group II Group III PVD 
No SD No SD No SD 
Present 1.55 0.35 1.85 0.25 - - 
Absent 0.72 0.25 1.21 0.5 0.59 0.1 
‘p’ 
 
0.0205   
Significant 
 
0.0015   
Significant - 
 
 
Mean CIMT was 1.55mm in group I cases with evidence of PVD compared to 0.72 mm  
 
in those without PVD. CIMT was 1.85 mm in group II cases with evidence of PVD  
 
compared to 1.21 mm in cases without PVD. 
 
The association was statistically significant in group I (p=0.0205) and group II  
 
(p=0.0015). 
 
From the table, it  is evident that CIMT is significantly associated with the prevalence of   
 
PVD in diabetes. 
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DISCUSSION 
Type 2diabetic patients often have diffuse and multiple cardiovascular lesions, despite having 
less symptoms than nondiabetic subjects. In fact, the onset of CAD may be a severe or fatal 
event in diabetic patients. The prognosis of cardiovascular events in diabetic patients tends to 
be worse than that in nondiabetic subjects. Carotid intima media thickness is one of the ways 
to screen asymptomatic diabetic patients for significant CAD. 
In the present study, we investigated the association between carotid atherosclerosis 
(measured from IMT) and CAD in Indian patients with asymptomatic type 2 diabetes 
mellitus. 
 
AGE: 
 The mean age group of patients in the study was 51 yrs and the highest number of 
patients were in the age group of 40-60 yrs.The age distribution was equal among the three 
groups with no statistically significant difference (p=0.2135). 
            Of the 70 patients in this age group, CIMT value was maximum in the CAD group 
with a mean of 1.3 mm. Further, there was significant correlation of CIMT with advancing 
age which was statistically significant. This association is in concordance with Studies by J 
Ahmad  et al (48) and Hamma S et al (49) which also showed that CIMT increases with age.  
SEX: 
 There were 61 males and 19 females patients in the study.The mean CIMT was not 
statistically different between males and females in group I 0.83 vs. 0.66 mm (p=0.3089), 
group II 1.35 vs. 1.26 mm (p=0.7234) and group III 0.58 vs. 0.62 mm (p=0.6081). None of 
which was statistically significant. In our study, gender was not found to be an independent 
risk factor for CIMT.  
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BMI : 
In our study,  the mean BMI values were 26.4 in group I, 27.4 in group II and 25.6 in group 
III respectively. The corresponding mean CIMT values were 0.79 mm in group I, 1.33 mm in 
group II and 0.59 mm in group III, which showed significant difference between the groups 
(p=0.0001).   
            Studies done by Naomi Mitshuashi et al (50) and Kotsis, vasilios t. et al (51) showed 
similar association. An Indian study done by J Ahmad et al (48)  also showed significant 
correlation between increasing BMI and CIMT. 
 
 DURATION OF DM : 
In our study, highest value of CIMT was seen in patients who had duration of DM>15 years 
(1.3mm in group I and 1.7 mm in group II). The mean CIMT values showed increasing 
values as duration of DM increased, and the association was statistically significant 
(p=0.0136 in group I and p=0.0003 in group II). This is in concordance with the study done 
by J Ahmad et al (48) . 
                   On the contrary, in the study conducted by Naomi Mitsuhashi et al (50) , there was 
no significant association between duration of DM and CIMT (p=0.5054). This could be 
explained by the fact that this study used diabetics without evidence of CAD as control 
population, whereas in our study, they were included as cases and non-diabetics were used as 
controls. 
 
HYPERTENSION : 
In our study, hypertension was present in 32.5% of the diabetics(21.7% in group I and 50% in 
group II). Mean CIMT in hypertensive diabetics was 1.12mm compared to 0.7mm in non-
hypertensives in group I (p=0.0237). Mean CIMT was 1.61mm in hypertensive cases in 
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group II compared to 1.05 mm in non-hypertensive cases in group II (p=0.0032). This shows 
that hypertension is independently associated with CIMT.  
                 Massimo Puato et al (52) in in his work on CIMT and hypertension, also found that 
hypertension had a linear correlation with CIMT, which supports the findings of our study. 
 
SMOKING : 
 In our study, there was statistically significant association between mean CIMT values and 
smoking in diabetics with CAD group (p=0.01518). This shows  a significant relation of 
CIMT with the prevalence of smoking among diabetics with CAD. CIMT values of smokers 
in the Non- CAD diabetic group did not show any significance. This could be explained by 
the fact that cases in the CAD group had more number of risk factors for atherosclerosis 
compared to the Non-CAD group.  
                  In a study done by Masoume Sadegi et al (53) , there was similar results obtained , 
correlating CIMT with smoking. 
 
ALCOHOL : 
Our study showed that 32.5% of total cases were alcoholic. CIMT in alcoholics belonging 
to group I was 0.75 mm compared to 0.82 mm in non-alcoholics. The difference was not 
statisitically significant (p=0.95). CIMT in alcoholics belonging to group II was 1.46 mm 
compared to 1.25 mm in non- alcoholics in that group. The difference was again not 
statistically significant (p=0.1936). 
                    Hence, our study shows that CIMT does not correlate with alcohol intake. 
Study conducted by Zureik, Mahmoud MD, PhD et al (54) , comprising of a study 
population sample of 6216 subjects, showed that CIMT was not associated with alcohol 
consumption categories in the overall population. Weak and marginal positive 
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associations were observed between categories of alcohol consumption and carotid 
plaques in men (P=0.02 for linear trend). 
                  In another study conducted by Ulf Schminke et al (55) , in Germany, as a part 
of SHIP study, comprising 1230 men and 1190 women, with a cross-sectional design, 
alcohol use was found to be inversely correlated with carotid IMT as a surrogate marker 
of generalized atherosclerosis in men but not in women. 
                  Thus, the association of alcohol with CIMT is controversial, with different 
studies providing conflicting reports. Further studies with more stringent protocols are 
needed to clarify its role in subclinical atherosclerosis. 
 
FASTING HYPERGLYCEMIA : 
Our study showed that mean CIMT  significantly associated with fasting hyperglycemia 
in the CAD group,  compared to non-CAD patients,  with a ‘p’ value of 0.0046. 
In a similar study conducted by J Ahmad et al (48) , CIMT showed significant correlation 
with fasting plasma glucose (r=0.271, p<0.05). 
                  Khamseh ME et al (56) also showed that showed that fasting blood glucose is an 
important factor that may affect carotid intima-media thickness. 
 
TOTAL CHOLESTEROL : 
In our study, CIMT showed a significant association with hypercholesterolemia in diabetics 
belonging to both CAD (CIMT-1.6 vs. 0.97) and NON-CAD groups(CIMT 1.1 vs 0.59), 
compared to the controls. There was significant association among the CAD group compared 
to the non-CAD group (‘p’ value 0.016). 
               In the study conducted by Khamseh ME et al (56 ) , it was proved that 
Diabetic dyslipidemia  significantly affected the carotid intima media thickness. 
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RETINOPATHY : 
Our study shows that in CAD and NON-CAD cases, mean CIMT showed significant 
association with the prevalence of diabetic retinopathy, with ‘p’ values of  0.0097 (group I) 
and 0.0112(group II) respectively, compared to controls. 
                MOHAN REMA, MBBS, DO, PHD, FABMS  and VISWANATHAN MOHAN, 
MD, MRCP, PHD, DSC,FNASC et al (57) in the the Chennai Urban Rural Epidemiology 
Study (CURES-2) trial, which comprised of 600 type 2 diabetic subjects randomly selected 
from Chennai, showed that Mean values of IMT (0.93 _ 0.36 vs. 0.85 _ 0.21 mm, P _ 0.001) 
were significantly higher among diabetic subjects with retinopathy. 
 
NEPHROPATHY : 
Our study showed that CIMT was higher in diabetics with nephropathy in group I and  
group II.  The association showed statistical significance in group I (p=0.0205) and group 
II (p=0.0081).The strength of association was higher in cases with CAD. 
               The result shows that CIMT was signifaicantly associated with the prevalence of 
nephropathy in diabetics. 
                     The study by Nathan et al. (58) also illustrates the relation of microalbuminuria to    
vascular complications such as intima–media thickening.    
 
PERIPHERAL VASCULAR DISEASE : 
In our study, the prevalence of PVD among diabetics was 12.5%. 
Mean CIMT was 1.55mm in group I cases with evidence of PVD and  CIMT was 1.85 mm in 
group II cases with no evidence of PVD. The association was statistically significant in group 
I (p=0.0205) and  group II (p=0.0015), more so in cases with CAD. 
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From table 26, it  is evident that CIMT bears  a significant  correlation with PVD  in type 2 
diabetics. 
                 Ravi R Kasliwal  et al (59) showed that There was a significant correlation between 
brachial-ankle pulse wave velocity and both mean and maximum carotid intima-media 
thickness in patients with coronary artery disease (r =0.47, p <0.0001 and r=0.41, p < 0.0008 
respectively) but not in individuals without coronary artery disease (r=0.01 and -0.1) 
respectively. 
                Our study is in line with the above study, proving that CIMT has a significant 
association with PVD in Diabetics with CAD. Hence, PVD could be a strong predictor of 
CAD in diabetes,along with CIMT. 
 
ASSOCIATION OF CIMT WITH CAD IN TYPE 2 DIABETES : 
In our study, there was a 54% prevalence of CAD among asymptomatic type 2 diabetes 
mellitus patients. Studies conducted by Garcia et al (60) and Bax JJ et al (61) also showed a 
very high prevalence of CAD among asymptomatic diabetics.  
The mean value of CIMT  was 0.79+0.35 mm in group I, 1.33+0.52 mm in group II and 
0.59+0.1 mm in group III respectively. 
There was statistically significant  difference in CIMT between the CAD group with  
Non-CAD group and controls.  
There was no significant difference in CIMT value between Non-CAD group and 
controls. 
              This agrees with the studies done by Naomi Mitsuhashi et al (50) ,  J Ahmad et al (48) , 
Daniel H. O’Leary et al (14) ,  Folsom AR et al (62) and Yoshimitsu yamasaki, MD, Phd et  al 
(20) . All these studies have shown significant association between CIMT and CAD in type 2 
diabetics. 
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ASSOCIATION OF CIMT WITH ASYMPTOMATIC CAD IN TYPE 2 DIABETES : 
 
 
Mean CIMT  was high in diabetics with Asymptomatic CAD (1.22mm) and MI cases      
(1.53 mm). The difference was not statistically significant between the groups  (p=0.0544). 
The results thus show that CIMT was associated with CAD in established MI cases as well as 
in asymptomatic diabetics. When compared to controls, mean CIMT was significantly 
associated with asymptomatic CAD group (p=0.0001). 
                  Our study is in concordance with the studies conducted by  Greenland, P et al (63) ,  
Simon, A et al (64) , Chambless et al (12) , Hodis HN et al (13) and O’Leary et al (14) . Thus our 
study shows significant association of CIMT in predicting asymptomatic coronary artery 
disease in type 2 diabetes mellitus patients. 
 
   LIMITATIONS OF THE STUDY :  
 
1. The non-CAD patients came from subjects with normal findings on the tread mill testing.   
    However, without coronary angiography, one cannot be completely sure that these 
    subjects were free of CAD.  This could be a limitation of our study. 
 
2. Nephropathy was evaluated only based on the urine – macroalbumin positivity, as facilities 
for detection of microalbuminuria was not available in our hospital. This could lead to 
underestimation of the prevalence of nephropathy in diabetes and it’s association with carotid 
intima media thickness. 
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CONCLUSION 
 
¾ The prevalence of  coronary artery disease (TMT positive cases in group II)  among 
asymptomatic type 2 diabetic patients was 54%. 
¾ Mean value of carotid intima media thickness was 1.06+0.4 mm. 
¾ Carotid intima media thickness was  significantly associated with coronary artery 
disease in asymptomatic patients with type 2 diabetes mellitus. 
¾ Age, smoking, body mass index, duration of DM, serum total cholesterol, fasting 
hyperglycemia, retinopathy, nephropathy and peripheral vascular disease showed 
correlation with significant carotid intima media thickness in type 2 diabetes 
mellitus patients. 
¾ Gender and alcoholism were not significantly associated with carotid intima media 
thickness in type 2 diabetes mellitus patients. 
¾ Our results indicate that early atherosclerosis in the carotid arteries 
            suggests a high probability of coronary involvement in patients with type 2 diabetes           
            mellitus.              
¾ If CIMT is increased in type 2 diabetic patients, further screening for CAD should 
be performed, and treatment should be initiated to prevent the progression of CAD. 
 
          
.  
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SUMMARY 
 
 
Coronary artery disease is a well recognized macrovascular complication in type 2 diabetes 
mellitus patients.  
                 This study was conducted to find the association between carotid intima media 
thickness and coronary artery disease among asymptomatic type 2 diabetes mellitus 
patients. 
                 After institutional ethical clearance, with an informed consent and with rigid 
inclusion and exclusion criteria, 65 patients and 15 controls were selected carefully and 
were evaluated on social, clinical and laboratory aspects. The data were entered in Micro 
soft Excel spread sheet and analyzed statistically. 
                The Mean age was 51 ±7.5 years. Among 65 type 2 diabetic patients 23 
belonged to non-CAD group, 42 belonged to the CAD group. The age groups of all the three 
groups were comparable and there was no statistical difference (p=0.2135). 
There were 61 males and 19 females patients in the study. The mean CIMT was not 
statistically different between males and females. 
There was significant relation of CIMT with the prevalence of smoking among 
diabetics with CAD. 
32.5% of total cases were alcoholic. There was no significant association between the 
prevalence of alcoholism and mean CIMT. 
 
CIMT was significantly associated with asymptomatic CAD in type 2 diabetes mellitus 
patients compared to the non-CAD group. 
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                 CAD, age, smoking, body mass index, duration of DM, serum total cholesterol, 
fasting hyperglycemia, retinopathy, nephropathy and peripheral vascular disease were all 
significantly associated with CIMT in type 2 diabetics.                    
                There is no significant relationship of CIMT with gender and alcoholism.  
                Further studies comprising of a large number of cases will be needed in the future 
to determine the exact value of carotid intima media thickness beyond which there will be a 
significant risk  of coronary events in type 2 diabetics. 
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    CASE    PROFORMA 
Name :       Age :   Sex :  OP/IP No: 
Occupation :      
Address :  
Phone : 
 
Chief Complaints : 
 
 
HISTORY : 
h/o HTN 
  h/o DM 
h/o smoking -  duration               pack years  
h/o alcoholism – duration           quantity 
 
GENERAL  EXAMINATION : 
Wt. -   Ht. -    BMI -      WHR –  
Pallor  Icterus  Cyanosis  Clubbing  Pedal edema 
JVP  Lymphadenopathy  Xanthomas  Skin tags Acanthosis 
VITALS : 
Pulse -   Rate  Rhythm  Character Volume 
Carotids     Femoral 
Radial      Popliteal  
Brachial      Post. Tibial 
Dorsalis pedis  
BP -  Rt. UL  Lt. UL   Rt. LL   Lt.LL 
RR –  
 
CVS :       
RS : 
P/A : 
CNS :      FUNDUS : 
 
INVESTIGATIONS : 
Blood Sugar – Fasting  Post-prandial 
Blood Urea     
Serum  creatinine 
Urine – Albumin  Sugar   Deposits    
Lipid Profile – TC  LDL  HDL  VLDL  TG 
ECG –  
TMT –  
CIMT -         Rt.                      Lt.                Mean  CIMT -  
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ECHO –  
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FASTING BLOOD SUGAR – GROUP DISTRIBUTION 
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EVALUATION OF CAROTID INTIMA MEDIA THICKNESS : 
 
EVALUATION OF CAROTID INTIMA MEDIA THICKNESS : 
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 POSITIVE EXERCISE INDUCED ISCHEMIA ON  TREADMILL  TEST  
 
 
 
 
 
 
 
 
